StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2026 it was -8.5%, against -0.1% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 2026-8.5%−8.3
FY2025Mar 31, 2025-0.1%−8.1
FY2024Mar 31, 20248.0%+0.0
FY2023Mar 31, 20237.9%–

More Cellyan Biotechnology figures

See a number that looks wrong?